|Conditional recommendation based on very-low-quality evidence; may consider an IL-17i if the patient has severe psoriasis or contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease.| |
|7. Switch to a TNFi biologic over adding MTX to an IL-12/23i biologic (PICO 36)|Very low|